Baseline characteristics
| Variables | Summary (n=10) |
| Age (years) | 62.7±9.1 |
| Male (n,%) | 8 (80%) |
| BMI (kg/m2) | 27.7±2.9 |
| Risk factors | |
| Active smoking (n, %) | 0 (0%) |
| Hypertension (n, %) | 8 (80%) |
| Dyslipidaemia (n, %) | 6 (60%) |
| Diabetes mellitus (n, %) | 1 (10%) |
| Cardiac and vascular disease | |
| Prior myocardial infarction (n, %) | 1 (10%) |
| Bicuspid aortic valve (n, %) | 3 (30%) |
| History of peripheral vessel disease (n, %) | 0 (0%) |
| History of COPD (n, %) | 0 (0%) |
| Medication | |
| Aspirin use (n, %) | 1 (10%) |
| Statin use (n, %) | 5 (50%) |
| Diuretic use (n, %) | 3 (30%) |
| Symptoms | |
| CCS score >1 (n, %) | 0 (0%) |
| NYHA score >1 (n, %) | 0 (0%) |
| Syncope (n, %) | 1 (10%) |
| Echocardiography | |
| Moderate aortic stenosis (n, %) | 7 (70%) |
| Ejection fraction at rest (%) | 66±4 |
| Mean pressure gradient AV (mm Hg) | 32±3 |
| AVA (cm2) | 1.0±0.9 (n=9) |
| AVA indexed (cm2/m2) | 1.1±0.3 (n=9) |
Summary values represent number (%) or mean±SD.
AV, aortic valve; AVA, aortic valve area measured with velocity time integral; BMI, body mass index; CCS, Canadian Cardiovascular Society grading of angina pectoris; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association.